CORXEL Pharmaceuticals's last reported valuation, Sep 2024. Nothing priced has surfaced since.
- ·The complete investor list: 13 names
- ·Watch CORXEL Pharmaceuticals: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
CORXEL Pharmaceuticals funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Later Stage VC (Series D1) | $287.0M | ▮ | ▮ |
Membership and data by Private Market View
CORXEL Pharmaceuticals valuation
CORXEL Pharmaceuticals's last reported valuation was $475 million in Sep 2024. No priced round, secondary trade or fund mark has surfaced since.
How much has CORXEL Pharmaceuticals raised?
CORXEL Pharmaceuticals has raised $452 million in total; 1 of its rounds is on record. The largest on record was a $287 million Series D1 in Jan 2026.
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Rivus Pharmaceuticals ($489 million), Electra Therapeutics ($479 million) and Diagonal Therapeutics ($459 million).
How CORXEL Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For CORXEL Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about CORXEL Pharmaceuticals
- What is CORXEL Pharmaceuticals worth?
- CORXEL Pharmaceuticals is valued at $474.9M as of Oct 2026. CORXEL Pharmaceuticals's last reported valuation, Sep 2024. Nothing priced has surfaced since.
- How much has CORXEL Pharmaceuticals raised?
- CORXEL Pharmaceuticals has raised $451.8M in total funding across 1 recorded rounds.
- When did CORXEL Pharmaceuticals last raise?
- CORXEL Pharmaceuticals last raised in Jan 2026 (Later Stage VC (Series D1)), raising $287.0M.